ReviewFrontiers in immunology2022
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases.
Li Jiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Li Jiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.